Appendicular lean mass and the risk of stroke and Alzheimer's disease: a mendelian randomization study

被引:0
|
作者
Zhu, Yueli [1 ,2 ]
Zhu, Feng [1 ,2 ]
Guo, Xiaoming [3 ]
Huang, Shunmei [1 ,2 ]
Yang, Yunmei [1 ,2 ]
Zhang, Qin [1 ,2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Geriatr, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Key Lab Diag & Treatment Aging & Phys Chem Injury, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Appendicular lean mass; Sarcopenia; Stroke; Alzheimer's disease; Mendelian randomization; FAT MASS; INSTRUMENTS; SARCOPENIA; ASSOCIATION; HEALTH;
D O I
10.1186/s12877-024-05039-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Appendicular lean mass (ALM) is a good predictive biomarker for sarcopenia. And previous studies have reported the association between ALM and stroke or Alzheimer's disease (AD), however, the causal relationship is still unclear, The purpose of this study was to evaluate whether genetically predicted ALM is causally associated with the risk of stroke and AD by performing Mendelian randomization (MR) analyses. Methods A two-sample MR study was designed. Genetic variants associated with the ALM were obtained from a large genome-wide association study (GWAS) and utilized as instrumental variables (IVs). Summary-level data for stroke and AD were generated from the corresponding GWASs. We used random-effect inverse-variance weighted (IVW) as the main method for estimating causal effects, complemented by several sensitivity analyses, including the weighted median, MR-Egger, and MR-pleiotropy residual sum and outlier (MR-PRESSO) methods. Multivariable analysis was further conducted to adjust for confounding factors, including body mass index (BMI), type 2 diabetes mellitus (T2DM), low density lipoprotein-C (LDL-C), and atrial fibrillation (AF). Results The present MR study indicated significant inverse associations of genetically predicted ALM with any ischemic stroke ([AIS], odds ratio [OR], 0.93; 95% confidence interval [CI], 0.89-0.97; P = 0.002) and AD (OR, 090; 95% CI 0.85-0.96; P = 0.001). Regarding the subtypes of AIS, genetically predicted ALM was related to the risk of large artery stroke ([LAS], OR, 0.86; 95% CI 0.77-0.95; P = 0.005) and small vessel stroke ([SVS], OR, 0.80; 95% CI 0.73-0.89; P < 0.001). Regarding multivariable MR analysis, ALM retained the stable effect on AIS when adjusting for BMI, LDL-C, and AF, while a suggestive association was observed after adjusting for T2DM. And the estimated effect of ALM on LAS was significant after adjustment for BMI and AF, while a suggestive association was found after adjusting for T2DM and LDL-C. Besides, the estimated effects of ALM were still significant on SVS and AD after adjustment for BMI, T2DM, LDL-C, and AF. Conclusions The two-sample MR analysis indicated that genetically predicted ALM was negatively related to AIS and AD. And the subgroup analysis of AIS revealed a negative causal effect of genetically predicted ALM on LAS or SVS. Future studies are required to further investigate the underlying mechanisms.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Genetically proxied appendicular lean mass and stroke risk: A two-step mendelian randomization study
    Li, Zhiming
    Liu, Xueyun
    Wen, Jianshang
    Wang, Zijie
    Xie, Yanfang
    Zhu, Lei
    Wu, Xiaosan
    Fang, Chuanqin
    Tian, Yanghua
    Li, Qi
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2024, 33 (10):
  • [2] Stroke and Alzheimer's Disease: A Mendelian Randomization Study
    Wang, Tao
    Ni, Qing-bin
    Wang, Kun
    Han, Zhifa
    Sun, Bao-liang
    [J]. FRONTIERS IN GENETICS, 2020, 11
  • [3] Gout and the risk of Alzheimer′s disease: A Mendelian randomization study
    Lee, Young Ho
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (06) : 1046 - 1051
  • [4] Genetically proxied lean mass and risk of Alzheimer's disease: mendelian randomisation study
    Daghlas, Iyas
    Nassan, Malik
    Gill, Dipender
    [J]. BMJ MEDICINE, 2023, 2 (01):
  • [5] Working status and risk of Alzheimer's disease: A Mendelian randomization study
    Zhao, Jiaxi
    Li, Kaixin
    Liao, Xiaoyang
    [J]. BRAIN AND BEHAVIOR, 2023, 13 (01):
  • [6] Amyloid, tau and risk of Alzheimer’s disease: a Mendelian randomization study
    Chris Ho Ching Yeung
    Kathleen Wen Din Lau
    Shiu Lun Au Yeung
    C. Mary Schooling
    [J]. European Journal of Epidemiology, 2021, 36 : 81 - 88
  • [7] Childhood obesity and risk of Alzheimer's disease: a Mendelian randomization study
    Qing, Wenxiang
    Qian, Yujie
    [J]. ARCHIVES OF PUBLIC HEALTH, 2024, 82 (01)
  • [8] Thyroid Function and the Risk of Alzheimer's Disease: A Mendelian Randomization Study
    Marouli, Eirini
    Yusuf, Lina
    Kjaergaard, Alisa D.
    Omar, Rafat
    Kus, Aleksander
    Babajide, Oladapo
    Sterenborg, Rosalie
    Asvold, Bjorn O.
    Burgess, Stephen
    Ellervik, Christina
    Teumer, Alexander
    Medici, Marco
    Deloukas, Panos
    [J]. THYROID, 2021, 31 (12) : 1794 - 1799
  • [9] Dietary factors and Alzheimer's disease risk: a Mendelian randomization study
    Meng, Qi
    Chen, Chen
    Zhu, Mingfang
    Huang, Yue
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01) : 261
  • [10] Amyloid, tau and risk of Alzheimer's disease: a Mendelian randomization study
    Yeung, Chris Ho Ching
    Lau, Kathleen Wen Din
    Au Yeung, Shiu Lun
    Schooling, C. Mary
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2021, 36 (01) : 81 - 88